Diabetes Risk Reduction Diet and Endometrial Cancer Risk.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
30 Jul 2021
Historique:
received: 17 06 2021
revised: 23 07 2021
accepted: 27 07 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 5 10 2021
Statut: epublish

Résumé

Diabetes increases endometrial cancer risk. We investigated the role of a diabetes risk reduction diet (DRRD) on the risk of endometrial cancer using data from a multicentric, Italian hospital-based case-control study (1992-2006) enrolling 454 histologically confirmed cases of endometrial cancer and 908 controls matched by age and center. We derived a DRRD score assigning higher scores for higher intakes of cereal fiber, fruit, coffee, polyunsaturated:saturated fatty acid ratio, and nuts and for lower glycemic load and lower intakes of red/processed meat and sugar-sweetened beverages/fruit juices. The odds ratios (OR) of endometrial cancer according to the DRRD score were derived by multiple conditional logistic regression models. The OR for high (DRRD score >24, i.e., third tertile) versus medium-low adherence to the DRRD was 0.73 (95% confidence interval, CI, 0.55-0.97). Similar results were observed after the exclusion of diabetic women (OR 0.75; 95% CI, 0.56-1.00) and allowance for total vegetable consumption (OR 0.80; 95% CI, 0.60-1.07). Inverse associations were observed in most of the analyzed subgroups. The OR for high DRRD combined with high vegetable consumption was 0.45 (95% CI, 0.28-0.73). Our results suggest that diets able to reduce diabetes risk may also reduce endometrial cancer risk. High vegetable consumption combined with high adherence to the DRRD may provide additional benefit in endometrial cancer prevention.

Identifiants

pubmed: 34444790
pii: nu13082630
doi: 10.3390/nu13082630
pmc: PMC8399314
pii:
doi:

Substances chimiques

Dietary Fiber 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Obstet Gynecol. 2009 Mar;200(3):293.e1-7
pubmed: 19091304
Eur J Cancer Prev. 2017 May;26(3):225-231
pubmed: 27222938
Cancer Epidemiol. 2015 Apr;39(2):170-3
pubmed: 25649355
Int J Gynecol Cancer. 2005 Sep-Oct;15(5):938-45
pubmed: 16174249
Eur J Cancer Prev. 2013 Jan;22(1):38-45
pubmed: 22584216
Public Health Nutr. 2011 Nov;14(11):1948-60
pubmed: 21752313
Ann Epidemiol. 2015 Oct;25(10):788-93
pubmed: 26260777
Nutr Cancer. 2002;44(1):16-22
pubmed: 12672637
Diabetologia. 2011 Feb;54(2):320-8
pubmed: 21046357
Eur J Cancer. 1993;29A(16):2298-305
pubmed: 8110502
Br J Cancer. 2013 Oct 1;109(7):1914-20
pubmed: 23922105
Cancers (Basel). 2020 Aug 06;12(8):
pubmed: 32781573
Am J Obstet Gynecol. 2009 Feb;200(2):130-5
pubmed: 19110217
Am J Gastroenterol. 2019 Dec;114(12):1870-1877
pubmed: 31688024
BMC Cancer. 2019 May 31;19(1):527
pubmed: 31151429
Diabetes Care. 2015 Apr;38(4):596-603
pubmed: 25592193
J Natl Cancer Inst. 2018 Apr 1;110(4):354-361
pubmed: 29045681
Sci Rep. 2015 Sep 11;5:14051
pubmed: 26360785
Diabetes Care. 2008 Dec;31(12):2281-3
pubmed: 18835944
Nutr Cancer. 2018 May-Jun;70(4):513-528
pubmed: 29708405
Br J Cancer. 2015 May 26;112(11):1816-21
pubmed: 26010500
Eur J Cancer Prev. 2021 Aug 16;:
pubmed: 34406178
Am J Epidemiol. 1993 Feb 15;137(4):393-403
pubmed: 8460621
Int J Mol Sci. 2011;12(5):3117-32
pubmed: 21686173
PLoS Med. 2007 Dec;4(12):e325
pubmed: 18076279
Nutr Cancer. 2012;64(5):643-51
pubmed: 22519904
J Nutr. 2002 Sep;132(9):2488-91
pubmed: 12221198
Br J Nutr. 2019 Sep 14;122(5):564-574
pubmed: 30526696
Nutrients. 2018 Jul 22;10(7):
pubmed: 30037138
Ann Epidemiol. 1996 Mar;6(2):110-8
pubmed: 8775590
Am J Clin Nutr. 2008 Jun;87(6):1793-801
pubmed: 18541570
Adv Nutr. 2021 Jul 30;12(4):1160-1176
pubmed: 33570108
Cancer Epidemiol. 2021 Feb;70:101855
pubmed: 33220638
Ann Oncol. 2011 Apr;22(4):884-889
pubmed: 20937645
Cancer Epidemiol Biomarkers Prev. 2021 Jun;30(6):1218-1228
pubmed: 33737302
Cancer Causes Control. 2007 Nov;18(9):957-66
pubmed: 17638105
Nutr Cancer. 2003;46(2):119-24
pubmed: 14690786
Int J Cancer. 2007 Dec 15;121(12):2741-7
pubmed: 17657712
Cancer Causes Control. 2007 Nov;18(9):967-88
pubmed: 17638104
Sci Rep. 2015 Sep 16;5:14243
pubmed: 26373341
Clin Nutr. 2020 Jun;39(6):1681-1691
pubmed: 31477367
Cancer Epidemiol. 2010 Oct;34(5):568-73
pubmed: 20619761
Int J Cancer. 2019 Feb 1;144(3):641-650
pubmed: 30289975
Br J Nutr. 2015 Apr;113 Suppl 2:S102-10
pubmed: 26148912
Eur J Nutr. 2021 Aug 2;:
pubmed: 34338866
Nutr Cancer. 2020;72(6):959-967
pubmed: 31584301
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Curr Opin Lipidol. 2002 Feb;13(1):3-9
pubmed: 11790957
Cancers (Basel). 2020 Jul 02;12(7):
pubmed: 32630728
BMC Cancer. 2017 Nov 13;17(1):757
pubmed: 29132343
Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):113-115
pubmed: 29284671
Ann Epidemiol. 1995 Jan;5(1):69-75
pubmed: 7728288
Acta Oncol. 2010 May;49(4):441-6
pubmed: 20148644
Int J Cancer. 2019 Oct 1;145(7):1719-1730
pubmed: 30387875
Gynecol Oncol. 2012 Jun;125(3):751-7
pubmed: 22449736
Nutr Cancer. 2007;58(1):6-21
pubmed: 17571962
J Clin Oncol. 2016 Dec 10;34(35):4277-4283
pubmed: 27903152
Med Sci Sports Exerc. 2019 Jun;51(6):1252-1261
pubmed: 31095082
Am J Epidemiol. 2009 Feb 15;169(4):462-72
pubmed: 19095757
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):978-89
pubmed: 21393567
Int J Cancer. 2003 Jun 20;105(3):404-7
pubmed: 12704677
Am J Clin Nutr. 2020 Dec 10;112(6):1492-1503
pubmed: 33022701
Nutrition. 2018 May;49:17-23
pubmed: 29571606
Lancet Oncol. 2017 Aug;18(8):e457-e471
pubmed: 28759385
Clin Nutr. 2020 Jul;39(7):2202-2210
pubmed: 31601449
Nutr Cancer. 2013;65(7):954-60
pubmed: 24053697
Am J Epidemiol. 2007 Oct 15;166(8):902-11
pubmed: 17690222
Curr Diab Rep. 2013 Apr;13(2):213-22
pubmed: 23271574
Clin Nutr ESPEN. 2021 Apr;42:22-31
pubmed: 33745582
Cancer Causes Control. 2007 Sep;18(7):687-703
pubmed: 17572853
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2384-94
pubmed: 24273064
Nutrients. 2019 Oct 02;11(10):
pubmed: 31581675
Am J Epidemiol. 1996 Oct 1;144(7):642-4
pubmed: 8823059
Br J Cancer. 1996 May;73(10):1284-90
pubmed: 8630294

Auteurs

Giovanna Esposito (G)

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milano, Italy.

Francesca Bravi (F)

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milano, Italy.

Diego Serraino (D)

Unit of Cancer Epidemiology, CRO Aviano National Cancer Institute, IRCCS, 33080 Aviano, Italy.

Fabio Parazzini (F)

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milano, Italy.
Department of Obstetrics, Gynecology and Neonatology-Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy.

Anna Crispo (A)

Epidemiology and Biostatistics Unit, Istituto Nazionale dei Tumori-IRCCS "Fondazione G. Pascale", 80131 Napoli, Italy.

Livia S A Augustin (LSA)

Epidemiology and Biostatistics Unit, Istituto Nazionale dei Tumori-IRCCS "Fondazione G. Pascale", 80131 Napoli, Italy.

Eva Negri (E)

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milano, Italy.
Department of Humanities, Pegaso Online University, 80143 Napoli, Italy.

Carlo La Vecchia (C)

Department of Clinical Sciences and Community Health, University of Milan, 20122 Milano, Italy.

Federica Turati (F)

Unit of Medical Statistics and Biometry, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, 20122 Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH